Search Results - "GULBA, D. C"

Refine Results
  1. 1

    Argatroban for elective percutaneous coronary intervention: The ARG-E04 multi-center study by Rössig, L, Genth-Zotz, S, Rau, M, Heyndrickx, G.R, Schneider, T, Gulba, D.C.L, Desaga, M, Buerke, M, Harder, S, Zeiher, A.M

    Published in International journal of cardiology (14-04-2011)
    “…Abstract The synthetic arginine-derived direct thrombin inhibitor argatroban is an attractive anticoagulant for percutaneous coronary intervention (PCI),…”
    Get full text
    Journal Article
  2. 2

    Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression : A potential link to accelerated arteriosclerosis by DECHEND, R, MAASS, M, GIEFFERS, J, DIETZ, R, SCHEIDEREIT, C, LEUTZ, A, GULBA, D. C

    Published in Circulation (New York, N.Y.) (28-09-1999)
    “…Background —Recent reports link C. pneumoniae infection of arteriosclerotic lesions to the precipitation of acute coronary syndromes, which also feature tissue…”
    Get full text
    Journal Article
  3. 3

    Medical compared with surgical treatment for massive pulmonary embolism by Gulba, D C, Schmid, C, Borst, H G, Lichtlen, P, Dietz, R, Luft, F C

    Published in The Lancet (British edition) (05-03-1994)
    “…We compared embolectomy (when available) with thrombolysis in patients with shock and massive pulmonary embolism. 13 patients were operated on, 10 (77%) of…”
    Get more information
    Journal Article
  4. 4

    Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine by Gulba, D C, Broscaru, L

    “…Since first used in 2009, non-vitamin K oral anticoagulants (NOAC) have gained world-wide acceptance. Two groups of NOAC are currently used: the direct…”
    Get full text
    Journal Article
  5. 5

    Stent implantation in patients with superior vena cava syndrome by Gross, CM, Kramer, J, Waigand, J, Uhlich, F, Schroder, G, Thalhammer, C, Dechend, R, Gulba, DC, Dietz, R

    Published in American journal of roentgenology (1976) (01-08-1997)
    “…The purpose of this study was to determine the feasibility of using Wallstent implantation to treat superior vena cava syndrome due to malignant tumors…”
    Get full text
    Journal Article
  6. 6

    Increased thrombin levels during thrombolytic therapy in acute myocardial infarction : relevance for the success of therapy by GULBA, D. C, BARTHELS, M, WESTHOFF-BLECK, M, JOST, S, RAFFENBEUL, W, DANIEL, W. G, HECKER, H, LICHTLEN, P. R

    Published in Circulation (New York, N.Y.) (01-03-1991)
    “…It has been suggested that thrombolysis in a feedback reaction may generate pro-coagulant activities. Fifty-five patients were treated with…”
    Get full text
    Journal Article
  7. 7

    Urokinase Activates the Jak/Stat Signal Transduction Pathway in Human Vascular Endothelial Cells by Dumler, Inna, Kopmann, Angela, Weis, Angelika, Mayboroda, Oleg A, Wagner, Kai, Gulba, Dietrich C, Haller, Hermann

    “…Endothelial cells demonstrate high urokinase expression and upregulation of urokinase receptors in response to vascular injury. Urokinase receptor binding…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin by Dumler, I., Stepanova, V., Jerke, U., Mayboroda, O.A., Vogel, F., Bouvet, P., Tkachuk, V., Haller, H., Gulba, D.C.

    Published in Current biology (16-12-1999)
    “…Background: Urokinase (uPA) and the urokinase receptor (uPAR) form a multifunctional system capable of concurrently regulating pericellular proteolysis,…”
    Get full text
    Journal Article
  11. 11

    Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes

    Published in The American heart journal (01-02-2001)
    “…Background Acute coronary syndromes (ACS), including the spectrum of conditions from unstable angina to ST segment elevation myocardial infarction, represent a…”
    Get full text
    Journal Article
  12. 12

    AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor by Dechend, R, Homuth, V, Wallukat, G, Kreuzer, J, Park, J K, Theuer, J, Juepner, A, Gulba, D C, Mackman, N, Haller, H, Luft, F C

    Published in Circulation (New York, N.Y.) (23-05-2000)
    “…We recently described autoantibodies (angiotensin-1 receptor autoantibodies, AT(1)-AA) directed at the AT(1) receptor in the serum of preeclamptic patients,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Ventricular remodeling after acute myocardial infarction by Dietz, R, Osterziel, K J, Willenbrock, R, Gulba, D C, von Harsdorf, R

    Published in Thrombosis and haemostasis (1999)
    “…The term ventricular remodeling has been coined to describe the geometrical changes in size and shape of the left ventricle occurring after large myocardial…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Die Bedeutung des uPA/uPAR-Systems für die Entwicklung von Arteriosklerose und Restenose by Kusch Angelika, D-C, Gulba

    Published in Clinical research in cardiology (01-05-2001)
    “…Zusammenfassung Arteriosklerose und die Entwicklung von Restenose stellen trotz neuer invasiver und medikamentöser Therapieformen immer noch ein…”
    Get full text
    Journal Article
  17. 17

    Renal artery embolism: thrombolysis with recombinant tissue-type plasminogen activator by Mügge, A, Gulba, D C, Frei, U, Wagenbreth, I, Grote, R, Daniel, W G, Lichtlen, P R

    Published in Journal of internal medicine (01-09-1990)
    “…The case of a patient with acute occlusion of the right renal artery due to an embolus is described. Using transoesophageal echocardiography, the left atrial…”
    Get more information
    Journal Article
  18. 18

    Thrombolysis in thromboembolic diseases by Gulba, D C, Dechend, R

    Published in Annals of hematology (01-10-1994)
    “…Thrombolysis in many manifestations of thromboembolic disease offers a valuable alternative to surgery. However, as thrombolysis is always associated with a…”
    Get full text
    Journal Article
  19. 19

    Urokinase Stimulates Human Vascular Smooth Muscle Cell Migration via a Phosphatidylinositol 3-Kinase-Tyk2 Interaction by Kusch, Angelika, Tkachuk, Sergey, Haller, Hermann, Dietz, Rainer, Gulba, Dietrich C., Lipp, Martin, Dumler, Inna

    Published in The Journal of biological chemistry (15-12-2000)
    “…Janus kinases Jak1 and Tyk2 play an important role in urokinase-type plasminogen activator (uPA)-dependent signaling. We have recently demonstrated that both…”
    Get full text
    Journal Article
  20. 20

    Thrombolytic agents--an overview by Gulba, D C, Bode, C, Runge, M S, Huber, K

    Published in Annals of hematology (1996)
    “…Thrombolysis today has become a routine option not only in the treatment of acute myocardial infarction but also in many other manifestations of thromboembolic…”
    Get full text
    Journal Article